Prologue: A Story with Sixteen Tellers |
|
1 | (4) |
|
|
|
|
Introduction: Health Universalism and the Health of Others |
|
5 | (24) |
|
|
|
|
|
|
9 | (1) |
|
|
10 | (5) |
|
|
15 | (1) |
|
|
16 | (4) |
|
What Is Neoliberal about Global Health? |
|
|
20 | (5) |
|
Multi-Scalar Methodologies |
|
|
25 | (4) |
|
1 Localization in the Global |
|
|
29 | (27) |
|
|
|
|
|
|
30 | (7) |
|
The Local as Site of Innovation |
|
|
37 | (6) |
|
SkyCare and the Virtual Global |
|
|
43 | (3) |
|
Community: The Discursive Local |
|
|
46 | (4) |
|
The Local as Hub of Global Circulations |
|
|
50 | (4) |
|
|
54 | (2) |
|
2 Metrics for Development |
|
|
56 | (22) |
|
|
|
|
|
Global Burden of Disease, Season 1 (GBD 1): The World Bank's Tool for Prioritizing Health Investments |
|
|
59 | (3) |
|
Putting GBD 1 to Use: The Real but Problematic "Economization" of National Investments in Health |
|
|
62 | (3) |
|
Global Burden of Disease, Season 2 (GBD 2): Limitations and Legitimation |
|
|
65 | (5) |
|
|
70 | (2) |
|
Crises of Ownership and Counting |
|
|
72 | (4) |
|
|
76 | (2) |
|
3 Triage beyond the Clinic |
|
|
78 | (25) |
|
|
|
|
|
Political Triage and Its Economic Alternative: The Primary Health Care Strategy and Its Eclipse |
|
|
81 | (2) |
|
Strategy in Practice: The Essential Drugs List and the Rise of the "Selective" Primary Health Care |
|
|
83 | (2) |
|
The 1990s and Its Aftermath: Performance-Based Triage and the World Bank |
|
|
85 | (4) |
|
Triage toward Disease Control: Tuberculosis and "Verticalization" in Global Health |
|
|
89 | (5) |
|
Comprehensive Primary Health Care, Medical Genetics, and Task Shifting in Oman |
|
|
94 | (4) |
|
Distributed Political Triage in Kerala |
|
|
98 | (3) |
|
|
101 | (2) |
|
4 Markets, Medicines, and Health Globalization |
|
|
103 | (21) |
|
|
|
|
|
Toward a Global Market: Branded Artemisinin Drugs Reaching Tanzania |
|
|
107 | (3) |
|
Rethinking Medicine Making: The Local Production of Generic Antimalarials in Ghana |
|
|
110 | (3) |
|
The Reformulation Regime: Industrial Ayurveda Goes Global |
|
|
113 | (5) |
|
Transactions at the Interstices: The Licit and Illicit Circulation of Drugs in Cambodia |
|
|
118 | (4) |
|
|
122 | (2) |
|
|
124 | (23) |
|
|
|
|
|
|
The Launching of a Depression Technopack |
|
|
128 | (3) |
|
|
131 | (4) |
|
GeneXpert: Of Genes and Experts |
|
|
135 | (3) |
|
Technopacking Genomics, Mestizaje, and Diabetes in Mexico |
|
|
138 | (4) |
|
Cuba's Prenatal Screening Technopack |
|
|
142 | (3) |
|
|
145 | (2) |
|
|
147 | (23) |
|
|
|
|
Crafting Medical Genetics in an Omani Hospital |
|
|
151 | (6) |
|
Providing Multidrug-Resistant Treatment in a Tuberculosis Hospital in Tanzania |
|
|
157 | (5) |
|
The Mental Hospital and Community Mental Health in India |
|
|
162 | (6) |
|
|
168 | (2) |
|
7 Provincializing the WHO |
|
|
170 | (24) |
|
|
|
|
|
|
|
Tuberculosis, the Making of DOTS, and the Decline of Primary Health Care |
|
|
173 | (3) |
|
The WHO and the World Bank: Revisiting the "Takeover" |
|
|
176 | (8) |
|
The WHO and the Missed Opportunity for a Global Agenda on Human Genetics, 1980S-2000S |
|
|
184 | (4) |
|
Transregional Health Encounters: Indian Ayurveda, African Markets, and the WHO's Guiding Principles |
|
|
188 | (4) |
|
A Road to Africa: China and Global Health |
|
|
192 | (2) |
Conclusion |
|
194 | (2) |
Epilogue: Global Health for All---COVID-19 and Beyond |
|
196 | (7) |
|
|
|
|
Acknowledgments |
|
203 | (2) |
Notes |
|
205 | (10) |
References |
|
215 | (26) |
Contributors |
|
241 | (2) |
Index |
|
243 | |